These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21700369)

  • 21. Tyrosine kinase inhibitors. 10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor.
    Rewcastle GW; Palmer BD; Thompson AM; Bridges AJ; Cody DR; Zhou H; Fry DW; McMichael A; Denny WA
    J Med Chem; 1996 Apr; 39(9):1823-35. PubMed ID: 8627606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3.
    Testard A; Logé C; Léger B; Robert JM; Lozach O; Blairvacq M; Meijer L; Thiéry V; Besson T
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3419-23. PubMed ID: 16644220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and structure-activity relationship of fused-pyrimidine derivatives as a series of novel GPR119 agonists.
    Negoro K; Yonetoku Y; Moritomo A; Hayakawa M; Iikubo K; Yoshida S; Takeuchi M; Ohta M
    Bioorg Med Chem; 2012 Nov; 20(21):6442-51. PubMed ID: 23010456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor.
    Smaill JB; Palmer BD; Rewcastle GW; Denny WA; McNamara DJ; Dobrusin EM; Bridges AJ; Zhou H; Showalter HD; Winters RT; Leopold WR; Fry DW; Nelson JM; Slintak V; Elliot WL; Roberts BJ; Vincent PW; Patmore SJ
    J Med Chem; 1999 May; 42(10):1803-15. PubMed ID: 10346932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (1) H and (13) C NMR assignments of four series bioactive pyrido[4,3-d]pyrimidine derivatives.
    Xu G; Song J; He J; Ren Q; Mo W; Xu H; Sun S; He H; Cui Y
    Magn Reson Chem; 2012 Sep; 50(9):646-50. PubMed ID: 22865687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
    El-Sayed Ali T
    Eur J Med Chem; 2009 Nov; 44(11):4385-92. PubMed ID: 19586688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bis[2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidin-1-ium] DL-malate.
    Franklin S; Balasubramanian T; Varghese B
    Acta Crystallogr C; 2009 Feb; 65(Pt 2):o62-5. PubMed ID: 19190390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors.
    Ibrahim DA; El-Metwally AM
    Eur J Med Chem; 2010 Mar; 45(3):1158-66. PubMed ID: 20045222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrogen-bonded ribbons in ethyl (E)-3-[2-amino-4,6-bis(dimethylamino)pyrimidin-5-yl]-2-cyanoacrylate and 2-[(2-amino-4,6-di-1-piperidylpyrimidin-5-yl)methylene]malononitrile.
    Trilleras J; Low JN; Cobo J; Marchal A; Glidewell C
    Acta Crystallogr C; 2008 Mar; 64(Pt 3):o145-8. PubMed ID: 18322341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct metalation of heteroaromatic esters and nitriles using a mixed lithium-cadmium base. Subsequent conversion to dipyridopyrimidinones.
    Bentabed-Ababsa G; Cheikh Sid Ely S; Hesse S; Nassar E; Chevallier F; Nguyen TT; Derdour A; Mongin F
    J Org Chem; 2010 Feb; 75(3):839-47. PubMed ID: 20030301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-d]pyrimidin-2-ones and 3,4-dihydropyrido[4,3-d]pyrimidin-2-ones.
    Natarajan SR; Wisnoski DD; Thompson JE; O'Neill EA; O'Keefe SJ
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4400-4. PubMed ID: 16750629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of nucleosides of 5,7-disubstituted pyrido [2,3-d] pyrimidines and their antibacterial activity.
    Gupta A; Prakash L
    Boll Chim Farm; 1994 Mar; 133(3):163-6. PubMed ID: 8011277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
    Colotta V; Lenzi O; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Traini C; Pedata F; Morizzo E; Moro S
    J Med Chem; 2009 Apr; 52(8):2407-19. PubMed ID: 19301821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
    Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C
    Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single step synthesis of new fused pyrimidine derivatives and their evaluation as potent Aurora-A kinase inhibitors.
    Shaaban MR; Saleh TS; Mayhoub AS; Farag AM
    Eur J Med Chem; 2011 Sep; 46(9):3690-5. PubMed ID: 21664013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four 2-aryl-8,8-dimethyl-6,7,8,9-tetrahydropyrazolo[2,3-a]quinazolin-6-ones: isolated molecules, hydrogen-bonded dimers, and pi-stacked chains of hydrogen-bonded dimers.
    Cruz S; Quiroga J; de la Torre JM; Cobo J; Low JN; Glidewell C
    Acta Crystallogr C; 2006 Jun; 62(Pt 6):o364-8. PubMed ID: 16763329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones: a novel class of selective human A-FABP inhibitors.
    Ringom R; Axen E; Uppenberg J; Lundbäck T; Rondahl L; Barf T
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4449-52. PubMed ID: 15357970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
    Gangjee A; Lin X; Kisliuk RL; McGuire JJ
    J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New 5H-[1,3]thiazolo[3,2-a]pyrido[3,2-e]pyrimidine derivatives as diuretics.
    Monge A; Martinez-Merino V; Sanmartin C; Ochoa MC; Fernandez-Alvarez E
    Arzneimittelforschung; 1990 Dec; 40(12):1349-52. PubMed ID: 2095131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of substituted thieno[2,3-d]pyrimidine-2,4-dithiones and their S-glycoside analogues as potential antiviral and antibacterial agents.
    Hafez HN; Hussein HA; El-Gazzar AR
    Eur J Med Chem; 2010 Sep; 45(9):4026-34. PubMed ID: 20691339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.